Seroepidemiology and chemoprophylaxis disease due to sulfonamide-resistant Neisseria meningitidis in a civillian population.
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000907:Antibodies, Bacterial; D002353:Carrier State / Q000188:drug therapy; D002555:Cerebrospinal Fluid / Q000382:microbiology; D002648:Child; D002675:Child, Preschool; D004196:Disease Outbreaks; D004352:Drug Resistance, Microbial; D005431:Florida; D006386:Hemagglutination Tests; D006798:Housing; D006801:Humans; D007106:Immune Sera; D007223:Infant; D008589:Meningococcal Infections / Q000188:drug therapy / Q000453:epidemiology* / Q000401:mortality / Q000517:prevention & control; D009305:Nasopharynx / Q000382:microbiology*; D009345:Neisseria meningitidis / Q000302:isolation & purification*; D012293:Rifampin / Q000627:therapeutic use; D012959:Socioeconomic Factors; D013449:Sulfonamides / Q000494:pharmacology*
D000907:Antibodies, Bacterial; D007106:Immune Sera; D013449:Sulfonamides; D012293:Rifampin